COMPANY PROFILE

Genesis Therapeutics

Unifying AI and Biotech We're pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines

San Mateo, United StatesFounded 2019Biotech & Life Sciences

Valuation $250–500M Last recorded · 2026

Headcount 100–500 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Genesis Therapeutics

Genesis Therapeutics is a biotech startup that leverages artificial intelligence (AI) to accelerate the development of new medicines. The company operates in the pharmaceutical industry, specifically in the drug discovery sector. Genesis Therapeutics uses a unique approach that combines 3D spatial graph modeling and advanced molecular simulation to generate potential drug candidates. This innovative method allows the company to explore untapped chemical spaces and unlock novel protein targets, which could lead to the discovery of critical new medicines.

Read full description

The company's clients primarily include other biotech and pharmaceutical companies. For instance, Genesis Therapeutics has announced a discovery deal with Eli Lilly, a major pharmaceutical company. This deal involves an upfront cash payment of $20M, with the potential total value reaching up to $670M. This indicates that Genesis Therapeutics operates on a business-to-business model, where it provides its AI-driven drug discovery services to other companies in the industry.

Genesis Therapeutics makes money through these strategic partnerships and deals with other companies. The company receives upfront payments and potential future payments based on the success of the drugs discovered through its platform. In addition, Genesis Therapeutics has successfully raised significant funding through investment rounds, including a $200M Series B round co-led by Andreessen.

In summary, Genesis Therapeutics is a pioneering biotech startup that uses AI to discover and develop new drugs, serving other companies in the pharmaceutical industry through strategic partnerships.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: San Mateo, United States
Employees: 168
Open positions: 6
Dealroom signal: 88.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Spinout, Tech for Biotech and Pharma, Rumoured $1B, Novel AI, Generative AI, AI Drug Discovery
Technology: Artificial Intelligence, Deep Tech
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	May 2026	$120M	$480M	Incyte	↗
LATE VCOther financing	Nov 2024	$0	—	NVentures	↗

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Genesis Therapeutics website traffic

Latest recorded traffic for Genesis Therapeutics is 12K monthly website visits, down 14.3% over the last three months. Genesis Therapeutics's team grew 10.5% over the past year.

Latest monthly visits12K 3-month web change-14.3% 1-year team growth+10.5%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Contract Recruiting CoordinatorNew York, New York, United States, Northern America, Americas · Human Resources · Sep 5, 2026 Product Management LeadSan Mateo, California, United States, Northern America, Americas · Project Management · Aug 11, 2026 Manager, New Product PlanningSan Diego, California, United States, Northern America, Americas · Project Management · Jul 30, 2026 ML & Molecular Simulation ScientistSan Mateo, California, United States, Northern America, Americas · Data Science & Engineering · Jun 12, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PRProfluentGenerative AI platform designing functional proteins for therapeutics	Emeryville, United States	Operational	78	$149M	$424M
BEBenchSciGenerating searchable results to help shorten the drug discovery process	Toronto, Canada	Operational
OWOwkinCollaborative research platform and unique AI drug development solutions that make precision medicine a reality	Paris, France	Operational
XTXaira TherapeuticsIntegrated biotechnology company focusing on leveraging artificial intelligence to transform drug discovery and development	Brisbane, United States	Operational
BIBioptimusUniversal AI foundation models for biological research	Paris, France	Operational
SMSuperluminal MedicinesGenerative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created	Boston, United States	Operational
CRCradleAI-powered protein design and engineering platform.	Amsterdam, Netherlands	Operational
OMOmniscopeAI-powered immune databank for diagnostics and therapeutics	Barcelona, Spain	Operational